DASH Diet in Heart Failure Outpatients (DASH-HF)

January 30, 2024 updated by: University of California, Davis

DASH Diet in Heart Failure Pilot Study - Integration and Effectiveness of Medical Nutrition Therapy Counseling on DASH Diet in the Management of Heart Failure Patients in an Academic Outpatient Cardiology Clinic

The purpose of this study is to refine the classification of the effectiveness of the DASH diet for outpatient heart failure (HF) management, using behavioral, clinical, and laboratory correlative science approaches.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

The overall objective of this pilot study is to refine the classification of the effectiveness of the DASH diet for outpatient HF management using behavioral, clinical, and laboratory correlative science approaches. The investigators will integrate the use and evaluation of DASH diet nutrition education in a clinical population using a pragmatic study approach. The investigators will assess dietary behavior change. The investigators will assess the medical effectiveness of the DASH diet to improve patient symptomology and clinical biomarkers. Exploratory investigations will involve metabolomics analyses of plasma samples for biomarker discovery of clinical phenotypes in HF patients, to characterize metabolic profiles related to dietary exposure.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • Sacramento, California, United States, 95817
        • UC Davis Health Center - Cardiology Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Heart Failure diagnosis
  • Guideline directed medical therapy optimization on stable regimen at least 30 days

Exclusion Criteria:

  • BMI < 18/5 kg/m squared
  • cardiac cachexia
  • end-stage renal disease or dialysis
  • acute inflammatory condition
  • uncontrolled arrhythmias or ischemia
  • status post heart transplant or implanted left ventricular assist device

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dietary Intervention Arm
Subjects will receive the active intervention of nutrition education and medical nutrition therapy counseling for dietary and behavioral lifestyle changes. The focus will be on DASH diet implementation and adherence for management of heart failure. The subjects will have 4 study visits with a Registered Dietitian over 6 months (visits at 1, 2, 3, and 6 months). Outcome measures will be assessed at baseline, 3 and 6 months.
Nutrition education and counseling on DASH diet, behavioral and lifestyle modifications

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary intake
Time Frame: Dietary intake at baseline
Dietary intake assessed by nutrient analysis of food records
Dietary intake at baseline
Dietary intake
Time Frame: Dietary intake at 3 months
Dietary intake assessed by nutrient analysis of food records
Dietary intake at 3 months
Dietary intake
Time Frame: Dietary intake at 6 months
Dietary intake assessed by nutrient analysis of food records
Dietary intake at 6 months
Diet score
Time Frame: Dietary intake at baseline
Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.
Dietary intake at baseline
Diet score
Time Frame: Dietary intake at 3 months
Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.
Dietary intake at 3 months
Diet score
Time Frame: Dietary intake at 6 months
Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.
Dietary intake at 6 months
Blood Pressure
Time Frame: Systolic and diastolic Blood Pressure at baseline
Blood Pressure assessed with systolic and diastolic pressure
Systolic and diastolic Blood Pressure at baseline
Blood Pressure
Time Frame: Systolic and diastolic Blood Pressure at 3 months
Blood Pressure assessed with systolic and diastolic pressure
Systolic and diastolic Blood Pressure at 3 months
Blood Pressure
Time Frame: Systolic and diastolic Blood Pressure at 6 months
Blood Pressure assessed with systolic and diastolic pressure
Systolic and diastolic Blood Pressure at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Failure clinical marker
Time Frame: proBNP at baseline
proBNP will be assessed as a marker of severity of heart failure
proBNP at baseline
Heart Failure clinical marker
Time Frame: proBNP at 3 months
proBNP will be assessed as a marker of severity of heart failure
proBNP at 3 months
Heart Failure clinical marker
Time Frame: proBNP at 6 months
proBNP will be assessed as a marker of severity of heart failure
proBNP at 6 months
Patient report of HF symptoms
Time Frame: KCCQ at baseline
Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.
KCCQ at baseline
Patient report of HF symptoms
Time Frame: KCCQ at 3 months
Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.
KCCQ at 3 months
Patient report of HF symptoms
Time Frame: KCCQ at 6 months
Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.
KCCQ at 6 months
Patient report of eating habit self efficacy
Time Frame: Eating Habits at Baseline
Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.
Eating Habits at Baseline
Patient report of eating habit self efficacy
Time Frame: Eating Habits at 3 months
Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.
Eating Habits at 3 months
Patient report of eating habit self efficacy
Time Frame: Eating Habits at 6 months
Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.
Eating Habits at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Francene Steinberg, PhD, University of California, Davis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Estimated)

February 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

November 1, 2021

First Submitted That Met QC Criteria

November 1, 2021

First Posted (Actual)

November 11, 2021

Study Record Updates

Last Update Posted (Estimated)

January 31, 2024

Last Update Submitted That Met QC Criteria

January 30, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1770356

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on DASH diet

3
Subscribe